Risk Factors for AD-Associated Switch to Mania

CompletedOBSERVATIONAL
Enrollment

221

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

January 31, 2010

Study Completion Date

July 31, 2011

Conditions
Bipolar Disorder
Interventions
DRUG

Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor( SNRI), and Tricyclics.

Risk for antidepressant-associated switch from depression to hypomania, mania, or mixed episode during the 8 weeks after the introduction of an antidepressant or after increasing the dosage of baseline antidepressant.

Trial Locations (1)

08037

Hospital Clinic Barcelona, Barcelona

All Listed Sponsors
lead

Hospital Clinic of Barcelona

OTHER

NCT01503489 - Risk Factors for AD-Associated Switch to Mania | Biotech Hunter | Biotech Hunter